In this exclusive interview, Sri shares his insights, experiences, and the philosophies that drive his professional success.
Sri S. Challa has carved a niche for himself in the realms of computer system validation, quality management, and compliance within the life sciences and technology sectors. With a robust background that spans various high-impact roles, Sri’s journey from a chemical engineering undergraduate to a leading figure in regulatory and quality management is nothing short of inspiring. In this exclusive interview, Sri shares his insights, experiences, and the philosophies that drive his professional success.
Q1: What initially drew you to the field of computer system validation and quality management?
A: My journey into computer system validation and quality management was somewhat serendipitous. While studying chemical engineering and biological sciences at BITS Pilani, I was fascinated by the rigorous processes and high standards required in the pharmaceutical and biotech industries. My subsequent Master’s in Biomedical Engineering at Rutgers University further solidified my interest in ensuring the highest quality and compliance standards. The transition into validation and quality management felt natural as it combined my technical knowledge with a passion for meticulous process control and regulatory adherence.
Q2: Can you describe a particularly challenging project you’ve worked on and how you overcame the obstacles?
A: One of the most challenging projects I led was at Verily Life Sciences, where we were developing a Laboratory Information Management System (LIMS) amidst the backdrop of the COVID-19 pandemic. The urgency and critical nature of the project required not only technical expertise but also the ability to manage a rapidly changing regulatory environment. We faced significant challenges in ensuring compliance while accelerating the development process. By fostering a collaborative environment, leveraging risk management strategies like FMEA, and maintaining open communication with all stakeholders, we successfully navigated these obstacles and delivered a robust solution.
Q3: How do you approach integrating new regulatory guidelines and standards into existing systems and processes?
A: Integrating new regulatory guidelines and standards is a systematic process. It begins with a thorough analysis of the new requirements and assessing their impact on current systems. At Celito Tech, for instance, we employ a risk-based approach to evaluate how these changes affect our products and processes. This involves updating our SOPs, conducting training sessions for the team, and ensuring that all changes are documented and validated. Continuous monitoring and feedback loops are essential to ensure that the integration is smooth and that compliance is maintained without disrupting ongoing operations.
Q4: Could you elaborate on the role of risk management in computer system validation and quality assurance?
A: Risk management is a cornerstone of both computer system validation and quality assurance. It involves identifying potential risks, assessing their impact, and implementing measures to mitigate them. At Betteromics, for example, we used risk-based validation to prioritize our efforts based on the criticality and intended use of the systems. Techniques such as FMEA and CAPA are instrumental in this process. By proactively managing risks, we can prevent issues before they arise and ensure that our systems are robust and reliable, ultimately safeguarding patient safety and data integrity.
Q5: What strategies do you employ to ensure continuous improvement in quality and compliance processes?
A: Continuous improvement is about fostering a culture that values feedback and innovation. One effective strategy is the implementation of regular audits and reviews, which help identify areas for improvement. At Illumina, we introduced electronic validation lifecycle management systems like ValGenesis, which streamlined our processes and facilitated continuous monitoring. Additionally, engaging cross-functional teams in brainstorming sessions and leveraging tools like Jira for tracking improvements have proven beneficial. Keeping abreast of industry trends and regulatory changes also ensures that our processes remain current and effective.
Q6: How do you handle the challenges of working across different geographical regions with varying regulatory requirements?
A: Working across different regions requires a deep understanding of local regulations and a flexible approach to compliance. At Gilead Sciences, for instance, we often had to navigate diverse regulatory landscapes. Establishing a global compliance framework that could be tailored to specific regional requirements was crucial. This involved close collaboration with local experts, continuous training for the team, and leveraging technology to ensure that our systems and processes were adaptable. Maintaining open lines of communication and a clear documentation trail also helped in managing these complexities effectively.
Q7: In your experience, what are the key elements of successful change management in a highly regulated environment?
A: Successful change management in a regulated environment hinges on meticulous planning, clear communication, and stakeholder engagement. At Celito Tech, for example, we ensure that every change initiative is accompanied by a detailed change control process. This includes risk assessments, impact analysis, and obtaining necessary approvals before implementation. Regular training sessions and clear documentation help in minimizing resistance and ensuring that everyone is on the same page. Continuous monitoring post-implementation ensures that the changes are effective and that any issues are promptly addressed.
Q8: How do you ensure effective collaboration between different departments to achieve common quality and compliance goals?
A: Effective collaboration is built on a foundation of mutual respect and open communication. At Verily Life Sciences, I facilitated cross-functional meetings and workshops to ensure alignment on quality and compliance objectives. Using collaborative tools like Google Workspace and Jira, we created transparent workflows where everyone could contribute and stay informed. Establishing clear roles and responsibilities and fostering a culture of accountability were also key. Regular updates and feedback sessions helped in maintaining momentum and ensuring that all departments were working towards the same goals.
Q9: What role does technology play in enhancing quality and compliance in the life sciences industry?
A: Technology plays a pivotal role in enhancing quality and compliance, providing tools that streamline processes, improve accuracy, and ensure regulatory adherence. Implementing systems like ValGenesis for electronic validation lifecycle management at Illumina significantly improved our efficiency and compliance tracking. Advanced analytics and AI can also help in predictive risk management and in identifying potential compliance issues before they become problematic. Technology enables us to maintain high standards of quality and compliance while also allowing for scalability and innovation in the life sciences industry.
Q10: What advice would you give to someone aspiring to build a career in quality management and compliance?
A: For anyone aspiring to build a career in quality management and compliance, my advice would be to develop a strong foundation in both the technical and regulatory aspects of the field. Continuous learning is crucial, as the regulatory landscape is always evolving. Gaining hands-on experience through internships or project work can be invaluable. Networking with professionals in the industry and joining relevant organizations like ASQ and ISPE can provide insights and opportunities for growth. Lastly, always approach challenges with a solution-oriented mindset and a commitment to maintaining the highest standards of quality and integrity.
Sri S. Challa’s journey through the intricate world of quality management and computer system validation serves as a testament to his expertise and dedication. His ability to navigate complex regulatory environments, drive continuous improvement, and foster collaboration across diverse teams has not only advanced his career but also contributed significantly to the organizations he has worked with. As Sri continues to push the boundaries of quality and compliance, his story inspires others to pursue excellence and make meaningful contributions to the life sciences industry.
